Royalty Report: Medical, Storage, Packaging & Containers – Collection: 710


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Medical
  • Storage
  • Packaging & Containers
  • Device
  • Specialty

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 710

License Grant
The Licensor shall train or arrange training for the SERVICE PROVIDER of China and other staff members of the SERVICE PROVIDER on the The Licensor's Stem Cell Services and SOPs.
License Property
The Licensor is a leader in adult stem cell collection, processing, cryopreservation and storage services and has rights to a range of proprietary stem cell technologies to be used in therapeutic applications.

The Service Provider is knowledgeable and experienced in the Asian healthcare market and wishes to obtain the exclusive rights to provide the Licensor's Stem Cell Services to a network of Centers.

“Stem Cell Collection” means that collection of human adult stem cells derived from peripheral blood and all related clinical procedures.

“Marks” means the “NEOSTEM” mark and name, and such other marks and names relating to the Business.

IPSCIO Record ID: 6088

License Grant
Licensor hereby grants to Licensee a non-exclusive, non-transferable, royalty-bearing license under the Licensed Patents in the Territory.
License Property
The Licensor holds certain patents relating to the storage, expansion and use of hematopoietic stem cells.

a. 'Collection' or 'Collected' means accumulation of or accumulated Cord Blood in a container.

b. 'Cord Blood' means blood or any blood components (including without limitation stem cells) collected from a human umbilical cord and/or placenta.

c. 'Cryopreservative' means an agent capable of preserving at very low temperatures.

d. 'Cryopreserve' means to preserve a material, such as Cord Blood or Stem Cells, by freezing.

e. 'Cryopreserved Blood' means (i) frozen Cord Blood, (ii) frozen and thawed Cord Blood or (iii) any other composition which would, but for this Agreement, infringe one or more claims of the Licensed Patents, in all three instances with or without a Cryopreservative.

g. 'Expanded Stem Cells' means Stem Cells, expanded from Cryopreserved Blood, or Cryopreserved after expansion.

i. 'Licensed Patents' means U.S. Patents Nos. 5,004,681, 5,192,553, 6,461,645, 6,569,427 and 6,605,275 and all patents that are related to any or all of those patents through priority or otherwise, directly or indirectly, including but not limited to, continuations, continuations in part, divisions, reissues and reexaminations thereof, and shall further include any other.

j. 'Licensed Process' means any process for the Collection, storage or use of Cord Blood that would, but for this Agreement, infringe one or more claims of Licensed Patents.

k. 'Modified Stem Cells' means Stem Cells, modified from Cryopreserved Blood, or Cryopreserved after modification.

Field of Use
The Licensee has the right to collects, processes and stores cord blood utilizing the Licensor's technology and processes covered by its patents for so long as the patents may remain in effect.

IPSCIO Record ID: 2806

License Grant
The Licensor entered into a definitive License and Royalty Agreement with the India Licensee to establish and market its C’elleSM menstrual stem cell preservation program in India and optionally, into the countries of Bangladesh, Nepal, Pakistan and Sri Lanka.  In consideration for the up-front License fee, the Licensor transferred its technology, know-how and quality systems to the Licensee. Once the Licensee has processed 10,000 specimens, the parties have agreed to renegotiate the royalty fee on collection, processing and storage revenues.
License Property
The C'elle(SM) service empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future utilization by the donor or possibly their first-degree relatives in a manner similar to umbilical cord blood stem cells.

IPSCIO Record ID: 3056

License Grant
The Licensor entered into a License Agreement with the Licensee to establish and market the Licensor's U-Cord business in Germany with the option to expand the Licensed territory to include Italy, Spain and France.
License Property
The Licensor is engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord®) blood stem cells for family use.
Field of Use
The Licensee has been providing families an opportunity to cryogenically preserve their newborn's umbilical cord blood stem cells in a safe and secure environment. This service is called U-Cord.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.